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Do Self-Management Interventions Work in Patients With Heart Failure? An
Individual Patient Data Meta-Analysis
Abstract
BACKGROUND: Self-management interventions are widely implemented in the care for patients with heart
failure (HF). However, trials show inconsistent results, and whether specific patient groups respond
differently is unknown. This individual patient data meta-analysis assessed the effectiveness of selfmanagement interventions in patients with HF and whether subgroups of patients respond differently.
METHODS AND RESULTS: A systematic literature search identified randomized trials of self-management
interventions. Data from 20 studies, representing 5624 patients, were included and analyzed with the use
of mixed-effects models and Cox proportional-hazard models, including interaction terms. Selfmanagement interventions reduced the risk of time to the combined end point of HF-related
hospitalization or all-cause death (hazard ratio, 0.80; 95% confidence interval [CI], 0.71-0.89), time to HFrelated hospitalization (hazard ratio, 0.80; 95% CI, 0.69-0.92), and improved 12-month HF-related quality of
life (standardized mean difference, 0.15; 95% CI, 0.00-0.30). Subgroup analysis revealed a protective
effect of self-management on the number of HF-related hospital days in patients(mean, 0.70 versus 5.35
days; interaction P=0.03). Patients without depression did not show an effect of self-management on
survival (hazard ratio for all-cause mortality, 0.86; 95% CI, 0.69-1.06), whereas in patients with moderate/
severe depression, self-management reduced survival (hazard ratio, 1.39; 95% CI, 1.06-1.83, interaction
P=0.01).
CONCLUSIONS: This study shows that self-management interventions had a beneficial effect on time to
HF-related hospitalization or all-cause death and HF-related hospitalization alone and elicited a small
increase in HF-related quality of life. The findings do not endorse limiting self-management interventions
to subgroups of patients with HF, but increased mortality in depressed patients warrants caution in
applying self-management strategies in these patients.
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Abstract
Background—Self-management interventions are widely implemented in care for patients with
heart failure (HF). Trials however show inconsistent results and whether specific patient groups
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respond differently is unknown. This individual patient data meta-analysis assessed the
effectiveness of self-management interventions in HF patients and whether subgroups of patients
respond differently.

Author Manuscript

Methods and Results—Systematic literature search identified randomized trials of selfmanagement interventions. Data of twenty studies, representing 5624 patients, were included and
analyzed using mixed effects models and Cox proportional-hazard models including interaction
terms. Self-management interventions reduced risk of time to the combined endpoint HF-related
hospitalization or all-cause death (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.71–
0.89), time to HF-related hospitalization (HR, 0.80; 95%CI, 0.69–0.92), and improved 12-month
HF-related quality of life (standardized mean difference 0.15; 95%CI, 0.00–0.30). Subgroup
analysis revealed a protective effect of self-management on number of HF-related hospital days in
patients <65 years (mean number of days 0.70 days vs. 5.35 days; interaction p=0.03). Patients
without depression did not show an effect of self-management on survival (HR for all-cause
mortality, 0.86; 95%CI, 0.69–1.06), while in patients with moderate/severe depression selfmanagement reduced survival (HR, 1.39; 95%CI, 1.06–1.83, interaction p=0.01).
Conclusions—This study shows that self-management interventions had a beneficial effect on
time to HF-related hospitalization or all-cause death, HF-related hospitalization alone, and elicited
a small increase in HF-related quality of life. The findings do not endorse limiting selfmanagement interventions to subgroups of HF patients, but increased mortality in depressed
patients warrants caution in applying self-management strategies in these patients.
Keywords
heart failure; individual patient data meta-analysis; self-management; subgroup analysis
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Heart failure (HF) is one of the most prevalent chronic conditions1 and despite advances in
medical treatment, patients diagnosed with HF face an increased risk of hospitalization and
mortality.2 The impact of HF on patients’ lives is substantial, as they are expected to adhere
daily to drug treatment, lifestyle changes and monitoring of signs and symptoms to prevent
decompensation.3 Self-management interventions, which aim at improving patients’
knowledge and skills to perform those behaviors and manage their condition, have received
increasing attention in care for patients with HF.

Author Manuscript

A meta-analysis on the effects of self-management interventions in patients with HF showed
significant reductions of all-cause and HF-related hospitalization in patients receiving the
self-management intervention, although there were no effects on mortality and quality of life
(QoL).4 A more recent systematic review, however, emphasized the heterogeneous findings
across studies.5 Several recently conducted large randomized controlled trials (RCTs) were
unable to show beneficial effects of self-management interventions on mortality or
hospitalization rates,6–9 further illustrating heterogeneity in observed effects.
Part of this heterogeneity may be attributable to varying trial designs, intervention
components, follow-up periods, or outcome assessments. Since individual RCTs included
different groups of patients, variations in patient characteristics are another likely source of
heterogeneity. Specific subgroups of patients might benefit more, or even might not benefit,
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from self-management interventions. Such knowledge will contribute to targeting selfmanagement interventions to those groups anticipated to benefit most, which may become
indispensable in times of decreasing resources.
Sample sizes in individual trials are generally too small to identify factors modifying the
success of self-management interventions. By combining data from multiple trials,
individual patient data (IPD) meta-analysis allows a reliable identification of patient
subgroups with a differential treatment response. Furthermore, IPD meta-analysis enables a
uniform definition of subgroups across studies, uniform imputation of missing data and
statistical analysis, and analysis of unreported endpoints.10 Additionally, the main effects of
included self-management interventions can be pooled and analyzed in a uniform manner.

Author Manuscript

This IPD meta-analysis aimed to evaluate effectiveness of self-management interventions
regarding HF-related or generic quality of life, HF-related or all-cause hospitalization, and
all-cause mortality and to identify subgroups of patients with HF that respond differently to
such interventions.

Methods
Data Sources and Study Selection
The electronic databases of PubMed, EMBASE, CENTRAL, PsycINFO and CINAHL were
searched from January 1985 through June 2013, as well as reference lists of systematic
reviews.

Author Manuscript
Author Manuscript

Studies were included if they (1) met the definition of self-management intervention, (2) had
a RCT design, (3) included patients with an established diagnosis of HF, (4) compared the
self-management intervention to usual care or another self-management intervention, (5)
reported data on one or more of the selected outcomes, (6) followed patients for at least six
months, and (7) were reported in English, Dutch, French, German, Italian, Portuguese, or
Spanish. Self-management interventions were defined as interventions providing
information to patients and minimally two of the following components: (1) stimulation of
sign/symptom monitoring, (2) education in problem solving skills, and enhancement of (3)
medical treatment adherence, (4) physical activity, (5) dietary intake, or (6) smoking
cessation. Studies were independently assessed by two researchers (NHJ and HW) on risk of
bias (low/unclear/high) using three criteria based on the ‘Risk of bias’ tool from the
Cochrane Collaboration11: (1) random concealed allocation to treatment, (2) intention-totreat analysis, and (3) other deviances (e.g., high drop-out, imbalances between groups). Any
discrepancies were solved through consensus with a third researcher (JCAT). Studies scoring
a high risk of bias on one or more criteria used from the ‘Risk of bias’ tool11 were defined as
‘high risk of bias’. Those studies were included in the analysis, but the impact of studies of
lower methodological quality was assessed in a sensitivity analysis by excluding these
studies.
Data collection
The principal investigators of selected studies were invited to participate in this IPD metaanalysis and share their de-individualized raw trial data. For details on the search syntax,
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collaboration with principal investigators, and a list of all requested variables, we refer to the
study protocol.12 Data from each trial were checked on range, extreme values, internal
consistency, missing values, and consistency with published reports. When recoding of
categorical variables was needed to create uniform categories, principal investigators were
consulted to ensure correct interpretation of variables. This IPD meta-analysis is exempt
from formal approval by the Medical Research Ethics Committee of University Medical
Center Utrecht, since it re-analyzes de-identified data from trials in which informed consent
has been obtained by principal investigators.
Outcomes

Author Manuscript

This study focused in the analysis on 8 main outcomes, divided into HF-related outcomes
and general outcomes. HF-related outcomes were time to the combined endpoint of HFrelated hospitalization or all-cause death, time to first HF-related hospitalization, total days
of HF-related hospital stay at 12 months, and HF-related quality of life (HF-QoL) at 12
months (measured with Heart Failure Symptom Scale,13 Kansas City Cardiomyopathy
Questionnaire,14 MacNew Heart Disease Health-related Quality of Life Instrument,15 or
Minnesota Living With Heart Failure Questionnaire16). General outcomes were generic QoL
at 12 months (measured with Short Form Health Survey 1217 or 3618), time to all-cause
death, time to first all-cause hospitalization, and total days of all-cause hospital stay at 12
months. In addition, outcomes at 6 months and binary outcomes for mortality and
hospitalization at 6 and 12 months were collected and analyzed, but are presented in
Supplemental Tables 1 and 2 as subordinate outcomes.
Patient-specific effect modifiers

Author Manuscript

Clinically relevant potential effect modifiers (i.e., variables, such as sex or age, that modify
the effect of self-management interventions) were selected based on the self-management
literature in HF patients19 and availability of comparable data across trials. The selected
patient characteristics are presented along with the baseline data in Table 1. We assumed that
these characteristics could modify the effect of interventions; e.g., self-management
interventions might be more effective in patients with only primary education compared to
higher educated patients.
Statistical analyses

Author Manuscript

Principal investigators were involved in designing a detailed plan for the statistical analysis
and agreed upon this prior to data analysis (see Supplemental Methods for detailed statistical
plan). Data from individual studies were merged to create one database. Using multiple
imputation by chained equations (25 imputations),21 missing values for baseline variables
and outcomes were imputed within studies. The imputed datasets were analyzed using a
one-stage approach (i.e., simultaneously analyzing all observations while accounting for
clustering of observations within studies).22 Results of imputed datasets were pooled using
Rubin’s rules and presented as the primary results.23
All analyses were performed according to the intention-to-treat principle. For time-to-event
endpoints, effects of self-management were quantified by estimating hazard ratios (HR)
using Cox proportional-hazard models, including a frailty term to account for clustering
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within studies. The continuous outcomes (HF-QoL and generic QoL) were quantified by
standardized mean differences (SMD) between intervention arms and analyzed using linear
mixed effects models. To correctly model the presence of overdispersion in count data of
total days of hospital stay, negative binomial mixed effects models were used to estimate
relative length of stay. Binary outcome data (all-cause mortality, all-cause, and HF-related
hospitalization) were analyzed with log-binomial mixed effects models, which estimated
risk ratios (RR). In case of non-convergence of a model, odds ratios (OR) were estimated
using a logistic mixed effects model, which is an addition to the published protocol.12 All
mixed effects models included a random intercept and random slope for the treatment effect
to take clustering within studies into account.

Author Manuscript

To assess whether the effect of self-management was modified by patient characteristics, the
aforementioned models were extended with interaction terms for categorical patient
characteristics included in Table 1. This was performed for each characteristic separately. If
there were two or more effect modifiers with p<0.10 for the interaction (likelihood ratio
test), the interaction terms were included in a multivariable model to estimate the effect of
self-management within subgroups independent of other relevant effect modifiers. Effect
modification was considered significant if the interaction term showed p<0.05 in the final
model.

Author Manuscript

As a sensitivity analysis, we investigated potential retrieval bias (i.e., selective inclusion of
studies in the IPD meta-analysis). Published main effects of studies for which we could not
obtain the original data (and thus were not included in the IPD meta-analysis) were pooled
in a random effects meta-analysis, together with the main effects of included studies. We
repeated the main effects analysis by excluding the studies with enhanced usual care. To
assess the impact of studies of lower methodological quality, a sensitivity analysis was
performed excluding studies with a high risk of bias. Three additional sensitivity analyses
assessed the robustness of the effect modifier analysis: (1) complete-case analysis to assess
the effect of imputing data, (2) analyses restricted to newer studies (recruitment since 2000),
and (3) excluding studies one-by-one to assess if the observed subgroup effects are
attributable to a specific study. All analyses were done in R for Windows version 3.1.1 (R
Development Core Team, Vienna).

Results

Author Manuscript

Thirty-two studies (n=8737) met the inclusion criteria and principal investigators were
approached to participate in this IPD meta-analysis. The investigators of five studies could
not be contacted, IPD of three studies were no longer available, and investigators of four
studies were not willing to participate. This resulted in inclusion of data of 20 RCTs,
representing 5624 patients in total.
Patient characteristics for which baseline data were available are presented in Table 1. A
majority of patients was male (57.2%) and mean age was 69.7 years (SD 12.4). Mean leftventricular ejection fraction (LVEF) was 39.2% (SD 18.2) and 26.0% of patients had a
preserved ejection fraction (≥50%). Median time since diagnosis of HF was 1.6 years (IQR
0.1–5.4). Baseline characteristics of patients included in this IPD meta-analysis were similar
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to those of patients in eligible studies that did not provide original data, except for the
percentage males and current smokers (resp. 63.8% and 11.2% in non-participating studies).
Characteristics of included studies are presented in Table 2. Sample size ranged from 4231 to
1023 patients.7 The majority of interventions were delivered by a specialized nurse, two
interventions used a group approach,29,39 and two interventions consisted of telephonic case
management.36,37 One trial included two intervention arms.7 Duration of the interventions
ranged from 0.525,30 to 187 months. Two studies provided “enhanced care” to the control
patients,6,29 consisting of some educational components. These components were judged
marginal and in line with the education delivered to HF patients in usual care. Consequently,
these two studies were included in the analysis.
Main effects of self-management interventions

Author Manuscript

Self-management interventions showed significant effects on several HF-related outcomes
(Table 3). Interventions reduced risk of time to the combined endpoint of HF-related
hospitalization or all-cause death (HR, 0.80; 95% confidence interval [CI], 0.71–0.89) and
time to HF-related hospitalization alone (HR, 0.80; 95% CI, 0.69–0.92). There was a small
improvement in HF-QoL at 12 months in patients receiving the intervention (SMD, 0.15;
95% CI, 0.00–0.30). No effects were found for total days in hospital due to HF readmissions
or any of the general outcomes. Figure 1 shows the effects across studies for HF-QoL, HFrelated hospitalization, and all-cause mortality.
Effects in patient subgroups

Author Manuscript
Author Manuscript

In the HF-related outcomes, subgroup analysis revealed significant effect modification by
age on days in hospital due to HF (Table 3). For younger patients (<65 years), mean number
of days in hospital due to HF in the intervention group was 0.70 days, while this was
5.35days in the control group (relative length of stay, 0.09; 95% CI, 0.02–0.38). This
difference was not found in patients aged 65–80 years (3.30 days in intervention group vs.
3.84 days in control group, interaction p=0.03). For general outcomes (Table 3), there was
significant effect modification by comorbid depression on time to all-cause death. While no
significant effect of self-management was found in patients with no/mild depression on allcause death (HR, 0.86; 95% CI, 0.69–1.06), there was a negative effect in patients with
moderate/severe depression on all-cause death (HR, 1.39; 95% CI, 1.06–1.83, interaction
p=0.01). In univariable analysis, level of education showed significant effect modification on
time to first all-cause hospitalization with lower educated patients showing a positive effect
of the self-management intervention (HR, 0.82; 95% CI, 0.71–0.96, Supplemental Table 3),
while there was no effect in patients who had completed secondary education (HR, 0.98;
95% CI, 0.82–1.17), or higher education (HR, 1.26; 95% CI, 0.99–1.60; interaction p=0.02).
After adjustment for potential effect modification by age, effect modification by level of
education was no longer significant (interaction p=0.07). Additional analyses of outcomes
measured at 6 months did not yield different insights (Supplemental Tables 1 and 2).
Sensitivity analyses
Including published effects of eligible studies for which original data could be obtained, did
not change the primary findings (Supplemental Table 4), neither did the sensitivity analysis
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of excluding studies with enhanced usual care (Supplemental Table 5). The other sensitivity
analyses also yielded similar effects. Only when subgroup analysis was repeated without the
trial by Jaarsma and colleagues,7 effect modification by depression on time to all-cause
death was no longer statistically significant (interaction p=0.22) and the negative effect for
patients with moderate/severe depression on all-cause death was no longer present (HR,
0.63, 95% CI, 0.29–1.34).

Discussion

Author Manuscript

To our knowledge, this study is the first IPD meta-analysis including sufficiently large
numbers of HF patients to be able to identify subgroups of patients that respond differently
to self-management interventions. We observed protective effects of self-management
interventions on time to the combined endpoint of HF-related hospitalization or all-cause
death, HF-related hospitalization alone and HF-QoL. Subgroup analyses showed that
younger patients responded better to self-management in terms of reduced total days of HFrelated hospitalization, and that HF patients with depression showed a reduced survival
following the self-management intervention.

Author Manuscript

The beneficial effects found on time to the combined endpoint of HF-related hospitalization
or all-cause death and on HF-related hospitalization alone have also been reported by
previous (aggregate data) meta-analyses on similar interventions.4,42 Earlier systematic
reviews consistently stressed the large heterogeneity across studies regarding effects of selfmanagement on health-related QoL.5 Our study included several recent large neutral trials6,7
and was the first to pool the results for HF-QoL and compute an overall effect. Although
95% confidence intervals were rather wide, we observed a small positive effect for HF-QoL
at 12 months. In contrast to HF-related outcomes, we found no effects of self-management
interventions on general outcomes (i.e., generic QoL, all-cause mortality, all-cause
hospitalization). This is in line with previous meta-analyses.4,42 Thus, it seems that selfmanagement interventions are particularly effective in HF patients for improving outcomes
directly related to their disease.

Author Manuscript

The subgroup analysis showed that younger patients (<65 years) benefited more from selfmanagement interventions than older patients. Younger patients in intervention groups were
discharged sooner from hospitalization for HF during follow-up than their counterparts in
control groups. There was no intervention effect in older patients. Older hospitalized patients
have an increased risk of functional decline, cognitive dysfunction and generally suffer from
more comorbid conditions, complicating their overall functioning and recovery time once
hospitalized.43 Especially older persons are at high risk in the period after hospitalization
due to deprived sleep, poor nutrition, stress, symptoms, new treatments, and inactivity.
Equipping patients with self-management skills might not be sufficient in such complex
situations. Post-discharge instability may need new approaches not only targeting HF itself
for a safer transition from hospital to home.44 Still, the effect modification by age was not
consistent across other health outcomes studied and the number of patients aged <65
included in the analysis was relatively small (n=139). The findings should therefore be
considered hypothesis-generating.

Circulation. Author manuscript; available in PMC 2017 March 22.

Jonkman et al.

Page 8

Author Manuscript
Author Manuscript

Self-management interventions increased the risk of all-cause mortality in patients with
moderate/severe depression. Sensitivity analyses indicated that this effect was driven by the
largest study included in this IPD meta-analysis.7 The authors of that study reported a
similar trend of their intervention for patients with depressive symptoms in their subgroup
analysis.45 These findings question the suitability of generic self-management interventions
in HF patients with depressive symptoms. Depression is often associated with reduced
motivation, which might compromise adherence to medication regimen and lifestyle
changes,46 particularly if multiple comorbid conditions (and treatment) need to be selfmanaged. These patients may be burdened with self-managing their HF. Increased mortality
following self-management interventions might therefore be caused by suboptimal
(self-)management of their illnesses, including HF. Interestingly, the negative effect was
limited to all-cause mortality. In the five studies that measured depression, self-management
interventions showed an overall HR of 0.95 on time to HF-related hospitalization (95% CI,
0.94–0.97) and subgroup analysis did not reveal a differential treatment effect between
patients with and without depression (HR depression, 1.00; 95% CI, 0.74–1.35; HR without
depression, 0.92; 95% CI, 0.71–1.18; interaction p=0.64). With no clear explanation for
reduced survival in HF patients with depression, caution is warranted before applying selfmanagement strategies in care for those patients. Patients with depressive symptoms might
need additional psychological interventions or medication before initiating self-management
interventions.47 Screening HF patients on symptoms of depression might help to determine
to what extent attention should be paid to self-management skills or additional psychological
interventions in the treatment plan.

Author Manuscript

Previous subgroup analyses in three large RCTs have shown that self-management
interventions might be more effective for patients with low socio-economic status. DeWalt
and colleagues found that only patients with low literacy showed a positive effect on HFrelated hospitalizations after self-management support.6 A Dutch self-management trial
found greatest improvements in health-related QoL in patients with lower education.48 The
third trial showed that patients with reduced income benefitted most from self-management.8
The pattern across studies generates the hypothesis that patients with a lower socioeconomic status may benefit most from self-management interventions. Similarly, our
analyses indicate a protective effect of self-management on time to first all-cause
hospitalization in patients with lower education. However, after adjusting for other potential
effect modifiers, this effect did not reach statistical significance.

Author Manuscript

This IPD meta-analysis was one of the first attempts to pool individual patient data on selfmanagement interventions for patients with HF. The study included sufficient patients
(n=5624) to analyze treatment effects in patient subgroups and applied robust statistical
modelling according to a pre-specified plan. Reported effects were found across cultures and
healthcare settings. Nevertheless, this study has several limitations that deserve further
discussion. First, despite numerous efforts to reach all principal investigators, we were
unable to include all 32 eligible trials. Inclusion of 62.5% (20/32) of eligible trials is
relatively high compared to IPD meta-analyses on similar interventions.49 Including
published results of trials for which no IPD were available did not change main effects, but
this could not be checked for the subgroup analysis due to limited published subgroup data.
Second, included self-management interventions differed in terms of intensity, duration,
Circulation. Author manuscript; available in PMC 2017 March 22.
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mode, and content. Although reported effects were found for self-management interventions
in any setting, specific types of interventions might work better for specific subgroups of
patients. Addressing the question “what works for whom?” deserves attention in subsequent
research. Third, this IPD meta-analysis was highly dependent on data previously collected in
individual studies which limited choice of potential effect modifiers to be studied. Individual
trials indicated that self-management interventions might be more effective in non-adherers
to regimens25 or in patients with better cognitive status.48 We could not analyze those
potential effect modifiers, since variables were not collected in all studies. If uniform
standards for baseline variables were established, a meaningful comparison of patient
subgroups across studies may provide further insight into patient characteristics modifying
treatment effects. Finally, although all (subgroup) analyses were pre-planned and
documented in our protocol,12 their large number increases the risk of false-positive
findings. Our subgroup analysis was exploratory in nature and not intended to demonstrate
causal mechanisms. Causal mechanisms of subgroup effects need to be completely
understood before any final conclusions can be drawn. Validation of our findings in large
trial databases may confirm our subgroup findings.

Conclusion

Author Manuscript

We found that despite diversity in intensity, content, and personnel delivering the
intervention, self-management interventions in patients with HF improve outcomes directly
related to their disease. Although self-management interventions might be more effective in
younger patients in reducing length of hospital stay, we did not observe consistent subgroup
effects across different health outcomes. This study does not endorse limiting selfmanagement interventions to specific subgroups of HF patients, but increased mortality in
depressed patients warrants caution in applying self-management strategies in these patients.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Forest plot of effects of self-management interventions on heart failure-related quality of
life, heart failure-related hospitalization, and all-cause mortality.
CI indicates confidence interval; HR, hazard ratio; and SMD, standardized mean difference.
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Table 1

Author Manuscript

Baseline characteristics of heart failure patients included in individual patient data meta-analysis.
Control

Intervention

Total

2674

2950

5624

Male

1505 (56.2)

1711 (58.0)

3126 (57.2)

Female

1169 (43.7)

1239 (42.0)

2408 (42.8)

Sample size, n
Sex

Age, y

69.9 ± 12.3

69.6 ± 12.4

69.7 ± 12.4

<65 years

796 (29.8)

917 (31.1)

1713 (30.5)

65–80 years

1358 (50.8)

1491 (50.5)

2849 (50.7)

>80 years

520 (19.4)

542 (18.4)

1062 (18.9)

Systolic dysfunction: LVEF

Author Manuscript

39.7 ± 18.4

38.7 ± 18.1

39.2 ± 18.2

>35% LVEF

805 (48.8)

903 (47.3)

1708 (48.0)

≤35% LVEF

846 (51.2)

1008 (52.7)

1854 (52.0)

NYHA I & II

1141 (45.2)

1317 (47.0)

2458 (46.1)

NYHA III

899 (35.6)

1065 (38.0)

1964 (36.9)

NYHA IV

484 (19.2)

422 (15.0)

906 (17.0)

401 (16.7)

556 (20.7)

957 (18.8)

NYHA class

Comorbidity index*
No comorbid conditions
Comorbid conditions in 1 cluster

925 (38.6)

991 (36.9)

1916 (37.7)

Comorbid conditions in >1 cluster

1070 (44.7)

1136 (42.3)

2206 (43.4)

No/mild depression

959 (73.9)

1169 (68.8)

2128 (71.0)

Moderate/severe depression

339 (26.1)

531 (31.2)

870 (29.0)

Primary education or below

807 (42.3)

910 (39.4)

1717 (40.7)

Secondary education

711 (37.3)

939 (40.6)

1650 (39.1)

Depression†

Author Manuscript

Level of education

Higher education

388 (20.4)

461 (20.0)

849 (20.1)

2.0 (0.1–6.0)

1.3 (0.1–5.2)

1.6 (0.1–5.4)

<1 year diagnosed

400 (41.3)

619 (46.2)

1019 (44.1)

1–2 years diagnosed

118 (12.2)

171 (12.8)

289 (12.5)

>2 years diagnosed

451 (46.5)

551 (41.1)

1002 (43.4)

Living with others

1064 (75.2)

1076 (73.2)

2140 (74.2)

Living alone

350 (24.8)

393 (26.8)

743 (25.8)

Years since diagnosis (median and interquartile range)

Living status

Body mass index

Author Manuscript

28.2 ± 6.9

27.9 ± 6.4

28.0 ± 6.6

<25

483 (34.2)

647 (36.1)

1130 (35.3)

25–29.99

508 (36.0)

611 (34.1)

1119 (35.0)

≥30

420 (29.8)

532 (29.7)

952 (29.7)

933 (79.9)

993 (82.1)

1926 (81.1)

Smoking status
Current non-smoker
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Current smoker

Control

Intervention

Total

234 (20.1)

216 (17.9)

450 (18.9)

Author Manuscript

LVEF indicates left ventricular ejection fraction; and NYHA, New York Heart Association.
Values are n(%), mean±SD or median(interquartile range).

*

Categories in the present IPD meta-analysis are based on clusters of the Cumulative Illness Rating Scale.20

†

Based on validated cut-off scores of instrument used in each specific study.

Author Manuscript
Author Manuscript
Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript

United
States

United
States

Netherlands

Netherlands

DeWalt, 20126

Heisler, 201329

Jaarsma, 199930

20087

Switzerland

Sweden

Japan

Germany

United
States

United
States

United
States

Leventhal,
201131

Martensson,
200532

Otsu, 201133

Peters-Klimm,
201034

Rich, 199535

Riegel, 200236

Riegel, 200637

Jaarsma,

Netherlands

Spain

Atienza,
200426

Bruggink,
200728

Spain

Aldamiz,
200725

United
Kingdom

Sweden

Agren, 201224

Blue, 200127

Country

Study
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135

358

282

197

102

153

42

1023

179

266

605

240

165

338

279

155

Sample
size

Telephonic casemanagement

Telephonic casemanagement

Clinic/hospital and home

Home (recruitment general
practice)

Clinic/hospital

Home (recruitment general
practice)

Clinic/hospital and home

Clinic/hospital

Clinic/hospital and home

Clinic/hospital and home

Clinic/hospital

Clinic/hospital

Clinic/hospital and home

Clinic/hospital

Clinic/hospital and home

Clinic/hospital or home

Setting

Telephone calls by nurse at decreasing intensity

Telephone calls by nurse at decreasing intensity

Daily visits by multidisciplinary professionals during
hospitalization, follow-up home visits and telephone calls by
nurse at decreasing intensity

1 individual session by nurse/physician, follow-up 3 home
visits and telephone calls

6 individual sessions by nurse

1 individual session by nurse, follow-up educational CDROM and telephone contact

1 home visit by nurse, educational booklet, follow-up 17
telephone calls

1: 2 individual sessions by cardiologist, 9 visits to nurse,
possibility to contact nurse
2: 2 individual sessions by cardiologist, 18 visits to nurse, 2
home visits, 2 multidisciplinary sessions, follow-up
regular telephone contact by nurse

1 home visit and 1 telephone call after discharge by nurse

1 group session by lay peer tutor, weekly telephone contact
with matched peer, follow-up 3 optional group sessions

1 individual session by health educator, follow-up multiple
telephone calls

2 individual sessions by nurse/physician, 1 telephone call,
follow-up 6 visits

Home visits by nurse, follow-up telephone calls with
intensity based on patient's needs

1 individual session before discharge by nurse, 1 visit to
physician, 3-monthly follow-up visits, and tele-monitoring

4 home visits by nurse/physician

3 individual sessions for patient and partner by nurse

Intervention group

Usual care

Usual care

Usual care

Usual care

Usual care

Usual Care

Usual care + booklet

Usual care

Usual care

Usual care + 1 group session
on self-management

Usual care + 1 session on
self-management and
educational manual

Usual care

Usual care

Usual care

Usual care

Usual care

Control group

Description of trials on self-management in heart failure patients included in individual patient data meta-analysis (N=20).

6

6

3

12

6

12

12

18

0.5

6

12

12

12

12

0.5

3

Duration
(months)*

Author Manuscript
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Netherlands
Sweden
Canada

Smeulders,
200939

Stromberg.
200340

Tsuyuki.
200441

276

106

317

406

Clinic/hospital

Clinic/hospital and home

Clinic/hospital

Clinic/hospital

Duration of the self-management intervention evaluated.

*

United
States

Author Manuscript

Sisk, 200638

Setting

Author Manuscript
Sample
size

1 individual session by pharmacist, follow-up 7 telephone
calls by nurse

1 visit after discharge to nurse, follow-up based on patient’s
status and needs (face-to-face and/or telephone)

6 group sessions by lay peer tutor and nurse, handbook,
follow-up telephone contact with co-participants

1 individual session by nurse, follow-up telephone calls

Intervention group

Author Manuscript

Country

Usual care + general heart
failure brochure

Usual care

Usual care

Usual care

Control group

Author Manuscript

Study

6

12

1.5

12

Duration
(months)*
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time-to-event

All-cause hospitalization

time-to-event

Mortality

HR

HR

MD

Generic QoL-MCS

12 months

MD

RLOS

HR

SMD

Generic QoL-PCS
12 months

General outcomes

12 months

Total days HF-related
hospital stay

time-to-event

HF-related hospitalization

12 months

HF-related QoL

time-to-event

HF-related hospitalization/
mortality

HR

Effect
size

Heart failure-related outcomes

Outcome

12

14

8

8

5

10

11

10

N
studies

3833

4312

1739

1739

892

3461

3356

3461

n
patients

0.93 (0.85–1.03)

0.91 (0.79–1.04)

0.27 (−2.53–3.08)

0.95 (−1.15–3.05)

0.86 (0.44–1.67)

0.80 (0.69–0.92)

0.15 (0.00–0.30)

0.80 (0.71–0.89)

Treatment
effect
(95% CI)

636

>80 years

541

296

1928
717

65–80 years
>80 years

1188

856

>80 years
<65 years

2224

65–80 years

1232

>80 years
<65 years

882

65–80 years

561

296

>80 years
<65 years

882

65–80 years

232

>80 years

561

521

<65 years

139

65–80 years

636

>80 years
<65 years

1739

65–80 years

1086

>80 years
<65 years

1607

65–80 years

1208

1739

65–80 years

<65 years

1086

n
patients

<65 years

Subgroups
Age

0.79 (0.64–0.97)

0.92 (0.81–1.05)

1.09 (0.91–1.31)

0.79 (0.62–1.00)

0.93 (0.78–1.11)

1.12 (0.80–1.56)

−1.19 (−5.62–3.24)

−0.26 (−3.49–2.97)

2.07 (−1.54–5.68)

1.13 (−2.01–4.26)

0.41 (−1.80–2.61)

1.84 (−0.74–4.42)

0.96 (0.31–2.97)

0.95 (0.46–1.94)

0.09 (0.02–0.38)

0.85 (0.63–1.15)

0.78 (0.64–0.94)

0.81 (0.62–1.07)

0.09 (−0.12–0.30)

0.12 (−0.04–0.29)

0.20 (0.02–0.38)

0.74 (0.58–0.95)

0.81 (0.69–0.95)

0.84 (0.66–1.07)

Treatment
effect
(95% CI)

0.07

0.25

0.37

0.63

0.03

0.88

0.65

0.77

p-value
for
interaction

Moderate/severe

No/mild

Moderate/severe

No/mild

Moderate/severe

No/mild

Moderate/severe

No/mild

Moderate/severe

No/mild

Moderate/severe

No/mild

Moderate/severe

No/mild

Moderate/severe

No/mild

Subgroups
Depression

Effects of self-management interventions in patients with heart failure included in individual patient data meta-analysis.

767

1469

814

1619

191

796

191

796

39

228

696

1274

772

1832

696

1274

n
patients

1.22 (1.00–1.49)

0.99 (0.84–1.15)

1.39 (1.04–1.87)

0.86 (0.69–1.06)

−2.91 (−9.36–3.54)

−0.88(−1.36–−0.39)

−1.29 (−5.67–3.09)

0.41 (0.09–0.73)

0.37 (0.01–9.70)

0.49 (0.13–1.84)

1.00 (0.74–1.35)

0.92 (0.71–1.18)

0.25 (−0.01–0.50)

0.16 (0.14–0.19)

1.05 (0.81–1.36)

0.81 (0.66–0.99)

Treatment
effect
(95% CI)

Author Manuscript

Table 3

0.10

0.01

0.52

0.45

0.94

0.64

0.41

0.12

p-value
for
interaction
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2304

0.97 (0.77–1.23)

Treatment
effect
(95% CI)
741
1110
453

65–80 years
>80 years

n
patients

<65 years

Subgroups
Age

0.77 (0.49–1.20)

0.98 (0.74–1.31)

1.14 (0.80–1.63)

Treatment
effect
(95% CI)
0.39

p-value
for
interaction

Moderate/severe

No/mild

Subgroups
Depression

359

1036

n
patients

0.90 (0.49–1.64)

1.06 (0.72–1.56)

Treatment
effect
(95% CI)

CI indicates confidence interval; HF, heart failure; HR, hazard ratio; MCS, mental component scale; MD, mean difference; PCS, physical component scale; QoL, quality of life; RLOS, relative length of
stay; and SMD, standardized mean difference.

12 months

RLOS

Author Manuscript

Total days all-cause
hospital stay

n
patients

Author Manuscript
N
studies

Author Manuscript

Effect
size

Author Manuscript

Outcome

0.45

p-value
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